Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by wyndeweston Jul 12, 2017 11:46am
237 Views
Post# 26460130

RE:RE:RE:RE:Just a thought from today's news

RE:RE:RE:RE:Just a thought from today's newsThanks for your post Himmler.  You have described a very realistic view regarding PLI/FDA .  Sadly we are sitting at a juncture where nothing  but positive news from the FDA will save the stock share price.  I don't see a partnership until the FDA weighs in. Anyway, after I read your post it made me think, "could Pierre & Co. have misread the FDA's positive encouragement?".  Several times PLI has mentioned good communications and working relationship with the FDA. I'm trying to be optimistic here.  Hopefully Pierre & Co. have not misread the situation. I do think the FDA's announced delays because of organizational changes and workload has put us at risk and all we can do is wait.... 
Bullboard Posts